News
-
-
PRESS RELEASE
Hyris Technology Supports the Fight Against One of the World’s Deadliest Diseases, Malaria
Hyris adapts molecular diagnostic technology for real-time surveillance of mosquito insecticide resistance, aiding malaria control. Prototype detects resistance in the field in under 3 hours, revolutionizing current testing approaches -
PRESS RELEASE
Hyris Fulfils Its Integration Into Ulisse Biomed to Give Birth to a New International Group Ready to Make Its Mark in the Global Biotech Market
Hyris and Ulisse Biomed have completed their corporate integration through a reverse take-over transaction, forming a new international biotech group with a focus on innovation in the genetic testing and diagnostics industry. The new group aims to become a leader in the in-vitro diagnostics industry, offering integrated diagnostic solutions and high-end performance products at a global level. The integration is expected to bring together the unique competencies and capabilities of both companies, creating a distinctive offer in the biotech market. -
